Cardiovascular Revascularization Medicine
Volume 7, Issue 2 , Pages 76-80 , April 2006

Recurrent myocardial ischemia due to riding left main coronary artery bifurcation thrombus—noninterventional therapy with glycoprotein blocker and thrombolysis

Received 8 November 2005 ,Revised 10 November 2005 ,Accepted 10 November 2005.

References 

  1. De Luca G, Suryapranata H, Thomas K, van‵t Hof AW, de Boer MJ, Hoorntje JC, et al. Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion. Am J Cardiol. 2003;91:235–238
  2. Gupta R, Rahman MA, Uretsky BF, Schwarz ER. Left main coronary artery thrombus: a case series with different outcomes. J Thromb Thrombolysis. 2005;19:125–131
  3. Marso SP, Steg G, Plokker T, Holmes D, Park SJ, Kosuga K, et al. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Am J Cardiol. 1999;83:1513–1517
  4. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology . Guidelines for percutaneous coronary interventions. Eur Heart J. 2005;26:804–847
  5. Chauhan A, Zubaid M, Ricci DR, Buller CE, Moscovich MD, Mercier B, et al. Left main intervention revisited: early and late outcome of PTCA and stenting. Catheter Cardiovasc Diagn. 1997;41:21–29
  6. Spiecker M, Erbel R, Rupprecht HJ, Meyer J. Emergency angioplasty of totally occluded left main coronary artery in acute myocardial infarction and unstable angina pectoris—institutional experience and literature review. Eur Heart J. 1994;15:602–607
  7. Deliargyris EN, Dehmer GJ, Willis PW. Adjunctive therapies in the cath lab. Successful medical therapy of left main thrombosis: value of serial coronary angiography. J Invasive Cardiol. 2001;13:644–646
  8. The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. Eur Heart J. 2004;25:166–181
  9. Michaels AD, Whisenant B, MacGregor JS. Multivessel coronary thrombosis treated with abciximab (ReoPro) in a patient with essential thrombocythemia. Clin Cardiol. 1998;21:134–138
  10. Rechavia E, Wurzel M. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery. Circulation. 1998;98:1249–1250
  11. Schlaifer JD, Horgan W, Malkowski MJ. Acute thrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab. Clin Cardiol. 2001;24:788
  12. Kakkar AK, Moustapha A, Hanley HG, Weiss M, Caldito G, Misra P, et al. Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting. Catheter Cardiovasc Interv. 2004;61:31–34
  13. Aydin M, Ozeren A, Bilge M. Acute incomplete thrombotic occlusion of distal left main coronary artery treated by tissue plasminogen activator. Heart. 2004;90:242
  14. Gambhir DS, Trehan V, Sudha R, Kaul UA, Arora R. Thrombotic occlusion if the left main coronary artery during stenting: successful management with intracoronary urokinase and autoperfusion balloon. Indian Heart J. 1996;48:273–275
  15. Lew AS, Weiss AT, Shah PK, Fishbein MC, Berman DS, Maddahi J. Extensive myocardial salvage and reversal of cardiogenic shock after reperfusion of the left main coronary artery by intravenous streptokinase. Am J Cardiol. 1984;54:450–452

PII: S1553-8389(05)00166-1

doi: 10.1016/j.carrev.2005.11.002

Cardiovascular Revascularization Medicine
Volume 7, Issue 2 , Pages 76-80 , April 2006

Article Tools

* Image Usage & Resolution